Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin

N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin

pharmaceutical raw materials
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin structure

N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin 

structure
  • CAS No:

    14636-12-5

  • Formula:

    C52H74N16O15S2

  • Chemical Name:

    N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin

  • Synonyms:

    [N-α-Triglycyl-8-lysine]-vasopressin;130: PN: WO2010033207 SEQID: 171 claiMed protein;1-Triglycyl-8-lysine Vasopressin;Nα-Glycyl-glycyl-glycyl-[8-lysine]-vasopressin;Nα-Glycyl-glycyl-glycyl-lysine-vasopressin;Nα-Glycylglycylglycyl-vasopressin;Nα-Gly-Gly-Gly-8-Lys-vasopressin;Triglycyl-8-lysine-vasopressin

  • Categories:

    Active Pharmaceutical Ingredients  >  Urinary System Drugs

Description

N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin is White Solid


Solid


Terlipressin is a polypeptide.|Terlipressin is an analogue of vasopressin used as a vasoactive drug in the management of hypotension which has been found to be effective when norepinephrine fails.|An inactive peptide prodrug that is slowly converted in the body to lypressin. It is used to control bleeding of ESOPHAGEAL VARICES and for the treatment of HEPATORENAL SYNDROME.

N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Basic Attributes

1227.37

1226.496094

238-680-8

DTXSID7048952

H01BA04|H - Systemic hormonal preparations, excl. sex hormones and insulins

Characteristics

563

-6.75

Solid

1.46±0.1 g/cm3(Predicted)

1824.0±65.0 °C(Predicted)

1056.9±34.3 °C

1.664

1.67e-01 g/L

0mmHg at 25°C

Safety Information

|Warning|H332 (100%): Harmful if inhaled [Warning Acute toxicity, inhalation]|P261, P271, P304+P312, P304+P340, and P312|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Toxicity

Approximately 30%

Drug Information

Commonly used to stop bleeding of varices in the food pipe (oesophagus).

Terlipressin is a medicine similar to a naturally occurring hormone present in the body, known as antidiuretic hormone (ADH) or vasopressin. ADH has two main effects in the body. Firstly, it causes narrowing of blood vessels (vasoconstriction), thereby limiting blood flow to a particular area of the body. It also acts on receptors in the kidney to retain water in the body, which helps to prevent excessive loss of water in the urine.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)|Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)

Terlipressin, an analogue of vasopressin, acts on three different receptors, vasopressin receptor V1a (which initiates vasoconstriction, liver gluconeogenesis, platelet aggregation and release of factor VIII), vasopressin receptor V1b (which mediates corticotrophin secretion from the pituitary) and vasopressin receptor V2 which controls free water reabsorption in the renal medullar. The binding of terlipressin to the V2 receptor activates adenylate cyclase which causes the release of aquaporin 2 channels into the cells lining the renal medullar duct. This allows water to be reabsorbed down an osmotic gradient so the urine is more concentrated.

glipressin

N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Use and Manufacturing

Terlipressin is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. Terlipressin is used norepinephrine-resistant septic shock and hepatorenal syndrome. Terlipressin is also used in the treatment of acute variceal bleeding.

Computed Properties

Molecular Weight:1227.4
XLogP3:-5.8
Hydrogen Bond Donor Count:16
Hydrogen Bond Acceptor Count:19
Rotatable Bond Count:25
Exact Mass:1226.49609806
Monoisotopic Mass:1226.49609806
Topological Polar Surface Area:563
Heavy Atom Count:85
Complexity:2380
Defined Atom Stereocenter Count:8
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

This drug is a precursor of lysine vasopressin. It is inactive by itself and acquires the physiological activity of vasopressin after being slowly converted into lysine vasopressin in the body. A proper amount of this drug can reduce portal blood pressure, but it will not significantly change arterial blood pressure like vasopressin, nor will it increase the dissolution of fibrin.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Ferring Pharmaceuticals (Asia) Co., Ltd.

    China China
    Active
  • Hunan Mingrui Pharmaceutical Co., Ltd.

    China China
    Active
  • Hybio Pharmaceutical (Wuhan) Co., Ltd.

    China China
    Active

Recommended Suppliers of N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin

Latest News on N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.